Literature DB >> 19655379

Variable FZD7 expression in colorectal cancers indicates regulation by the tumour microenvironment.

Elizabeth Vincan1, Dustin J Flanagan, Normand Pouliot, Thomas Brabletz, Simone Spaderna.   

Abstract

Recent evidence shows that a sub-population of Wnt/beta-catenin target genes is specifically induced in different tissue contexts. FZD7 is a putative Wnt/beta-catenin target gene and although it is highly expressed in well-differentiated colorectal cancer tumour cells, its expression is decreased in de-differentiated tumour cells at the invasive front despite elevated Wnt/beta-catenin signalling in this area. This variable expression of FZD7 implicates additional regulation by the microenvironment; however, this has not been investigated. To begin to elucidate the role of extracellular matrix in regulating FZD7 expression, we generated a FZD7 promoter reporter and analysed FZD7 promoter activity in colorectal cancer cells grown on different matrices. We demonstrate that the FZD7 promoter is regulated by beta-catenin in colorectal cancer cells and observed decreased promoter activity in cells grown on fibronectin but not collagen I or collagen IV. Thus, expression of FZD7 in colorectal cancer may be regulated by fibronectin in the microenvironment. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19655379     DOI: 10.1002/dvdy.22045

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  19 in total

1.  The WNT receptor FZD7 is required for maintenance of the pluripotent state in human embryonic stem cells.

Authors:  Antonio Fernandez; Ian J Huggins; Luca Perna; David Brafman; Desheng Lu; Shiyin Yao; Terry Gaasterland; Dennis A Carson; Karl Willert
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

Review 2.  Frizzled7 as an emerging target for cancer therapy.

Authors:  Taj D King; Wei Zhang; Mark J Suto; Yonghe Li
Journal:  Cell Signal       Date:  2011-12-13       Impact factor: 4.315

3.  Shiga-like toxin I exerts specific and potent anti-tumour efficacy against gastric cancer cell proliferation when driven by tumour-preferential Frizzled-7 promoter.

Authors:  Hongpan Xu; Lijun Peng; Mengjiao Shen; Yanyan Xia; Zhiyang Li; Nongyue He
Journal:  Cell Prolif       Date:  2019-04-06       Impact factor: 6.831

4.  Frizzled7 Activates β-Catenin-Dependent and β-Catenin-Independent Wnt Signalling Pathways During Developmental Morphogenesis: Implications for Therapeutic Targeting in Colorectal Cancer.

Authors:  Bang Manh Tran; Dustin James Flanagan; Toby James Phesse; Elizabeth Vincan
Journal:  Handb Exp Pharmacol       Date:  2021

Review 5.  Frizzled homolog proteins, microRNAs and Wnt signaling in cancer.

Authors:  Koji Ueno; Hiroshi Hirata; Yuji Hinoda; Rajvir Dahiya
Journal:  Int J Cancer       Date:  2012-08-30       Impact factor: 7.396

6.  Frizzled 7 expression is positively regulated by SIRT1 and β-catenin in breast cancer cells.

Authors:  Glenn E Simmons; Somnath Pandey; Ana Nedeljkovic-Kurepa; Madhurima Saxena; Allison Wang; Kevin Pruitt
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

7.  Captopril, a Renin-Angiotensin System Inhibitor, Attenuates Features of Tumor Invasion and Down-Regulates C-Myc Expression in a Mouse Model of Colorectal Cancer Liver Metastasis.

Authors:  Georgina E Riddiough; Theodora Fifis; Katrina A Walsh; Vijayaragavan Muralidharan; Christopher Christophi; Bang M Tran; Elizabeth Vincan; Marcos V Perini
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

8.  Invasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment.

Authors:  Kestutis Planutis; Marina Planutiene; Anthony V Nguyen; Mary Pat Moyer; Randall F Holcombe
Journal:  J Transl Med       Date:  2013-02-26       Impact factor: 5.531

9.  Microvascular invasion in hepatocellular carcinoma overexpression promotes cell proliferation and inhibits cell apoptosis of hepatocellular carcinoma via inhibiting miR-199a expression.

Authors:  Yang Shi; Qingwei Song; Shengcai Yu; Dianhe Hu; Xiaohu Zhuang
Journal:  Onco Targets Ther       Date:  2015-08-27       Impact factor: 4.147

10.  FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway.

Authors:  M Asad; M K Wong; T Z Tan; M Choolani; J Low; S Mori; D Virshup; J P Thiery; R Y-J Huang
Journal:  Cell Death Dis       Date:  2014-07-17       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.